Intelligent Bio Solutions Inc. (NASDAQ: INBS) completed its initial clinical Cut-off Study for FDA 510(k) submission of its fingerprint-based drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA